ID

18436

Descrizione

Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00193479

collegamento

https://clinicaltrials.gov/show/NCT00193479

Keywords

  1. 04/11/16 04/11/16 -
Caricato su

4 novembre 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0

Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Non-Hodgkins Lymphoma NCT00193479

Eligibility Non-Hodgkins Lymphoma NCT00193479

Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
to be included in this study, you must meet the following criteria:
Descrizione

Clinical Trial Eligibility Criteria Fulfill

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C1550543
histologically documented large b-cell, cd20-positive non-hodgkin's lymphoma
Descrizione

Diffuse Large B-Cell Lymphoma positive for CD20 antigen

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0079744
UMLS CUI [1,2]
C0882818
no previous treatment
Descrizione

Prior Therapy

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1514463
clinical stage ii, iii, or iv by the ann arbor staging criteria
Descrizione

Ann Arbor lymphoma staging system

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0432516
age > 70 years
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
ecog performance status 0, 1, or 2
Descrizione

ECOG performance status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1520224
adequate bone marrow, liver and kidney function
Descrizione

Bone Marrow function | Liver function | Renal function

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232741
UMLS CUI [3]
C0232804
must give written informed consent prior to entering this trial
Descrizione

Informed Consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
you cannot participate in this study if any of the following apply to you:
Descrizione

Clinical Trial Eligibility Criteria Fulfill

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C1550543
age < 18 years
Descrizione

Age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
central nervous system involvement with lymphoma
Descrizione

Lymphoma Central Nervous System Involvement

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0024299
UMLS CUI [1,2]
C4050309
coexistent active malignancies treated within five years
Descrizione

Malignant Neoplasm Treated

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C1522326
active infection precluding the use of combination chemotherapy
Descrizione

Communicable Disease Excludes Combination Chemotherapy

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0009450
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C1521750
hiv infection
Descrizione

HIV Infections

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0019693
pregnant or lactating
Descrizione

Pregnancy | Breast Feeding

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
Descrizione

Clinical Trial Eligibility Criteria Additional

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C1524062

Similar models

Eligibility Non-Hodgkins Lymphoma NCT00193479

Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
Clinical Trial Eligibility Criteria Fulfill
Item
to be included in this study, you must meet the following criteria:
boolean
C1516637 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Diffuse Large B-Cell Lymphoma positive for CD20 antigen
Item
histologically documented large b-cell, cd20-positive non-hodgkin's lymphoma
boolean
C0079744 (UMLS CUI [1,1])
C0882818 (UMLS CUI [1,2])
Prior Therapy
Item
no previous treatment
boolean
C1514463 (UMLS CUI [1])
Ann Arbor lymphoma staging system
Item
clinical stage ii, iii, or iv by the ann arbor staging criteria
boolean
C0432516 (UMLS CUI [1])
Age
Item
age > 70 years
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
ecog performance status 0, 1, or 2
boolean
C1520224 (UMLS CUI [1])
Bone Marrow function | Liver function | Renal function
Item
adequate bone marrow, liver and kidney function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232741 (UMLS CUI [2])
C0232804 (UMLS CUI [3])
Informed Consent
Item
must give written informed consent prior to entering this trial
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Clinical Trial Eligibility Criteria Fulfill
Item
you cannot participate in this study if any of the following apply to you:
boolean
C1516637 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
Age
Item
age < 18 years
boolean
C0001779 (UMLS CUI [1])
Lymphoma Central Nervous System Involvement
Item
central nervous system involvement with lymphoma
boolean
C0024299 (UMLS CUI [1,1])
C4050309 (UMLS CUI [1,2])
Malignant Neoplasm Treated
Item
coexistent active malignancies treated within five years
boolean
C0006826 (UMLS CUI [1,1])
C1522326 (UMLS CUI [1,2])
Communicable Disease Excludes Combination Chemotherapy
Item
active infection precluding the use of combination chemotherapy
boolean
C0009450 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C1521750 (UMLS CUI [1,3])
HIV Infections
Item
hiv infection
boolean
C0019693 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or lactating
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Clinical Trial Eligibility Criteria Additional
Item
please note: there are additional inclusion/exclusion criteria. the study center will determine if you meet all of the criteria. if you do not qualify for the trial, study personnel will explain the reasons. if you do qualify, study personnel will explain the trial in detail and answer any questions you may have.
boolean
C1516637 (UMLS CUI [1,1])
C1524062 (UMLS CUI [1,2])

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial